Table 3.
Variable | No. # N = 346 | 3-year OS (%) | p-value | 3-year LRFS (%) | p-value | 3-year DFS (%) | p-value |
---|---|---|---|---|---|---|---|
Age | 0.002 | 0.001 | 0.008 | ||||
<50 y | 225 | 87 | 97 | 80 | |||
≥50 y | 121 | 75 | 87 | 69 | |||
N-stage | 0.003 | 0.685 | 0.024 | ||||
N0 | 63 | 92 | 94 | 84 | |||
N1 | 110 | 87 | 92 | 77 | |||
N2 | 113 | 84 | 94 | 77 | |||
N3 | 60 | 67 | 96 | 65 | |||
T-stage | 0.105 | 0.838 | 0.050 | ||||
T3 | 59 | 90 | 95 | 88 | |||
T4 | 287 | 82 | 93 | 74 | |||
Overall stage | 0.038 | 0.684 | 0.024 | ||||
III | 53 | 92 | 94 | 91 | |||
IV | 293 | 82 | 94 | 74 | |||
Chemotherapy | 0.386 | 0.059 | 0.427 | ||||
Yes | 327 | 84 | 94 | 77 | |||
No | 19 | 72 | 83 | 68 | |||
Prescribed dose | 0.926 | 0.985 | 0.793 | ||||
≤73.92 Gy | 311 | 83 | 93 | 76 | |||
>73.92 Gy | 35 | 85 | 94 | 75 | |||
Residual tumor* | 0.007 | 0.002 | <0.001 | ||||
No | 205 | 90 | 97 | 82 | |||
Yes | 141 | 73 | 89 | 67 |
*Residual tumor: tumor detected by MRI at the end of radiotherapy.
#No.: number of patients.
OS: overall survival; LRFS: local relapse-free survival; DFS: disease-free survival.